Repository landing page

We are not able to resolve this OAI Identifier to the repository landing page. If you are the repository manager for this record, please head to the Dashboard and adjust the settings.
oaioai:HAL:hal-01767765v1

Health-Related Quality of Life in Chronic HCV-Infected Patients Switching to Pegylated-Interferon-Free Regimens (ANRS CO20 CUPIC Cohort Study and SIRIUS Trial)

Authors
Publication date
1 October 2017
Publisher
'Springer Science and Business Media LLC'
Doi

    Abstract

    International audienceWe aimed to compare health-related quality of life (HRQL) during and after hepatitis C virus (HCV) treatment in patients receiving pegylated-interferon (PEG-IFN)-containing therapy (including boceprevir or telaprevir-ANRS CO20 CUPIC cohort) who subsequently switched to PEG-IFN-free regimens (sofosbuvir + ledipasvir with or without ribavirin [RBV]-SIRIUS trial)

    Similar works

    Full text

    thumbnail-image

    HAL Descartes

    redirect
    oaioai:HAL:hal-01767765v1
    Last time updated on 07/01/2019

    This paper was published in HAL Descartes.

    Having an issue?

    Is data on this page outdated, violates copyrights or anything else? Report the problem now and we will take corresponding actions after reviewing your request.